UnitedHealth Group (NYSE:UNH) Issues FY21 Earnings Guidance


Share on StockTwits

UnitedHealth Group (NYSE:UNH) updated its FY21 earnings guidance on Thursday. The company provided earnings per share guidance of $18.10-18.60 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $18.22. UnitedHealth Group also updated its FY 2021
Pre-Market guidance to 18.10-18.60 EPS.

UnitedHealth Group stock opened at $391.01 on Friday. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.59. The stock’s 50 day moving average is $360.10 and its 200-day moving average is $342.73. UnitedHealth Group has a 12 month low of $273.25 and a 12 month high of $392.36. The company has a market capitalization of $369.63 billion, a price-to-earnings ratio of 22.46, a PEG ratio of 1.55 and a beta of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share for the quarter, topping the consensus estimate of $4.38 by $0.93. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The business had revenue of $70.20 billion during the quarter, compared to analysts’ expectations of $69.13 billion. During the same quarter in the previous year, the company earned $3.72 EPS. The business’s revenue was up 9.0% on a year-over-year basis. As a group, equities research analysts predict that UnitedHealth Group will post 16.75 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 23rd. Shareholders of record on Monday, March 15th were issued a $1.25 dividend. The ex-dividend date was Friday, March 12th. This represents a $5.00 annualized dividend and a yield of 1.28%. UnitedHealth Group’s dividend payout ratio is presently 33.09%.

A number of research analysts recently commented on the company. BMO Capital Markets boosted their price target on UnitedHealth Group from $410.00 to $435.00 and gave the company a market perform rating in a research note on Friday. Oppenheimer upped their price target on shares of UnitedHealth Group from $375.00 to $440.00 and gave the stock an outperform rating in a report on Friday. Stephens lifted their price objective on shares of UnitedHealth Group from $415.00 to $425.00 and gave the company an overweight rating in a research note on Friday. Mizuho upped their target price on UnitedHealth Group from $380.00 to $394.00 and gave the stock a buy rating in a research note on Thursday. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $409.00 to $418.00 and gave the stock a buy rating in a report on Friday. Four analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of Buy and an average price target of $407.77.

In related news, Director Richard T. Burke sold 4,000 shares of the firm’s stock in a transaction on Monday, March 15th. The stock was sold at an average price of $353.32, for a total value of $1,413,280.00. Following the completion of the sale, the director now owns 153,953 shares of the company’s stock, valued at $54,394,673.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 619 shares of the firm’s stock in a transaction dated Tuesday, February 9th. The stock was sold at an average price of $323.90, for a total transaction of $200,494.10. Following the completion of the sale, the chief accounting officer now directly owns 31,908 shares of the company’s stock, valued at $10,335,001.20. The disclosure for this sale can be found here. Insiders sold 9,619 shares of company stock valued at $3,292,774 in the last quarter. Corporate insiders own 0.80% of the company’s stock.

A hedge fund recently bought a new stake in UnitedHealth Group stock. OLD Mission Capital LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 1,409 shares of the healthcare conglomerate’s stock, valued at approximately $439,000. Hedge funds and other institutional investors own 86.03% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

Read More: Balanced Fund

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.